Phase @ , multicenter , open-label , dose-ranging , randomized clinical trial ( AMETHYST-DN ) , conducted at @ sites in Europe from June @ to June @ evaluating patiromer in @ outpatients with type @ diabetes ( estimated glomerular filtration rate , @ to < @ mL/min/@ @ m@ and serum potassium level > @ mEq/L ) .